NuVasive, Inc.

The momentum for this stock is not very good. NuVasive, Inc. is not very popular among insiders. NuVasive, Inc. is a mediocre stock to choose.

NuVasive, Inc. engages in the development of minimally-disruptive surgical products and procedurally...

News

ProShare Advisors LLC Boosts Stock Position in NuVasive, Inc. (NASDAQ:NUVA)

Zolmax ProShare Advisors LLC lifted its position in NuVasive, Inc. (NASDAQ:NUVA Free Report) by 75.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange...\n more…

Rhumbline Advisers Purchases 6,488 Shares of NuVasive, Inc. (NASDAQ:NUVA)

Zolmax Rhumbline Advisers increased its holdings in NuVasive, Inc. (NASDAQ:NUVA Free Report) by 4.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the...\n more…

NuVasive, Inc. (NASDAQ:NUVA) Shares Bought by FORA Capital LLC

Ticker Report FORA Capital LLC raised its position in NuVasive, Inc. (NASDAQ:NUVA Free Report) by 59.9% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional...\n more…

Public Sector Pension Investment Board Lowers Stock Holdings in NuVasive, Inc. (NASDAQ:NUVA)

Ticker Report Public Sector Pension Investment Board reduced its stake in NuVasive, Inc. (NASDAQ:NUVA Free Report) by 3.3% during the 1st quarter, according to its most recent filing with the Securities...\n more…

US Bancorp DE Has $30,000 Holdings in NuVasive, Inc. (NASDAQ:NUVA)

Zolmax US Bancorp DE lowered its holdings in NuVasive, Inc. (NASDAQ:NUVA Free Report) by 41.2% in the first quarter, according to its most recent 13F filing with the Securities & Exchange...\n more…

NuVasive (NASDAQ:NUVA) Coverage Initiated by Analysts at StockNews.com

Zolmax Analysts at StockNews.com started coverage on shares of NuVasive (NASDAQ:NUVA Get Free Report) in a research note issued on Saturday. The firm set a hold rating on the medical...\n more…